Putnam Investments’s PDL BioPharma, Inc. PDLI Stock Holding History

Putnam Investments’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-519,100	Closed	-$2.61M	–	1549
2015 Q3	$2.61M	Hold	519,100	–	–	0.01%	915
2015 Q2	$3.34M	Sell	519,100 -148,200	-22%	-$993K	0.01%	881
2015 Q1	$4.69M	Buy	667,300 +20,400	+3%	+$148K	0.01%	800
2014 Q4	$4.99M	Hold	646,900	–	–	0.01%	784
2014 Q3	$4.83M	Buy	646,900 +42,400	+7%	+$394K	0.01%	785
2014 Q2	$5.85M	Sell	604,500 -143,500	-19%	-$1.28M	0.01%	716
2014 Q1	$6.22M	Buy	748,000 +689,699	+1,183%	+$5.91M	0.01%	665
2013 Q4	$492K	Sell	58,301 -875	-1%	-$7.37K	﹤0.01%	1352
2013 Q3	$472K	Sell	59,176 -114,685	-66%	-$922K	﹤0.01%	1354
2013 Q2	$1.34M	Buy	+173,861	New	+$1.36M	﹤0.01%	1152

Other funds holding PDLI

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Gotham Asset Management New York $43B AUM 34.97% 1-Year Est. Return

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Advisors Asset Management Monument, Colorado $6.56B AUM 35.09% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Putnam Investments's PDLI Position: Q4 2015 in Review

Putnam Investments sold out of PDL BioPharma, Inc. (PDLI) in Q4 2015, closing a stake of 519,100 shares — an estimated $2.61M sold.

Putnam Investments first reported a position in PDLI in Q2 2013 and held it in 10 quarters. The position peaked at $6.22M in Q1 2014. 204 funds tracked by Wall St. Rank hold PDLI as of Q4 2015.

Putnam Investments reported no remaining PDL BioPharma, Inc. position as of Q4 2015 after selling out during the quarter.
Putnam Investments sold 519,100 PDL BioPharma, Inc. shares in Q4 2015, an estimated $2.61M.
Putnam Investments first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 10 quarters.
Putnam Investments's PDL BioPharma, Inc. position peaked at $6.22M in Q1 2014.
204 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2015.

Based on Putnam Investments's 13F filing for Q4 2015, filed 16 Feb 2016.